Anatomic Pathology Equipment: US Market Assessment
45 Hospital Laboratory Directors From Across the United States
Deliverable: PowerPoint presentation with key findings.
STUDY DESCRIPTION
|
Topic |
Advanced slide staining techniques |
|
Respondent Type |
Laboratory Directors |
|
Specialties Covered |
Pathology |
|
Region |
United States Only |
|
Methodology |
Online survey, self-administered via a Panel Intelligence website § A 20-minute duration § Fielded online from January 23 - February 1, 2007
|
OBJECTIVES
To gain insight from laboratory directors regarding hardware and consumables used for primary and advanced slide staining techniques.
§ Explore any difficulties lab directors currently face in finding or training histotechnologists
§ Determine current and future H&E slide preparation workload
· Specify the hardware components that are being used currently and what will be used in the next year
§ Determine current and future advanced slide preparation workload
· Specify the hardware components or integrated systems that are being used currently and what will be used in the next year
· Specify the reagents, probes and detection systems that are being used currently and what will be used in the next year
§ Assess reaction to the SYMPHONY H&E Preparation System
· Gauge likelihood to purchase
· Understand potential impact of acquiring and using this system
Companies and Products Mentioned in This Report
|
Company |
Ticker Symbol |
Product(s) |
|
Ventana Medical Systems Inc. |
VMSI |
SYMPHONY H&E Preparation System |
Inclusion Criteria and Respondent Demographics
|
Inclusion Criteria
|
§ Oversee a lab that performs either primary (H&E) or advanced [(In Situ Hybridization (ISH), Fluorescent ISH (FISH) or Immunohistochemistry (IHC)] staining techniques § Must be familiar with the budget process for purchasing the equipment or supplies in their lab § Must have at least some input in the decision-making process for purchasing equipment or supplies in their lab. |
| © Panel Intelligence, LLC. 1999-2008. All rights reserved. A wholly owned subsidiary of MCF Corporation (NASDAQ: MERR) Privacy Policy |